Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | FDPS | P14324 | 5/20 | 0.42 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.40 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.35 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.34 |
| ▸ | FLT1 | P17948 | 1/20 | 0.34 |
| ▸ | GRK5 | P34947 | 1/20 | 0.34 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20533249 | 1.00 | ALDH1A1 (0.45) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL9308664 | 0.77 | FDPS (0.46) | ALDH1A1MEN1KMT2AFDPSGRM4 | |
| SCHEMBL9802369 | 0.77 | FDPS (0.41) | FDPSGRM4SMPD1LMNA | |
| SCHEMBL10360956 | 0.76 | NAALAD2 (0.41) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL27771082 | 0.75 | ALDH1A1 (0.43) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL6770526 | 0.75 | FDPS (0.48) | FDPSGRM4SMPD1LMNA | |
| SCHEMBL5918828 | 0.75 | FDPS (0.62) | FDPSGRM4SMPD1 | |
| SCHEMBL3379180 | 0.74 | MEN1 (0.41) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL7111437 | 0.74 | NAALAD2 (0.44) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL1933286 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140271926-A1 | METHODS OF USE OF GLUTAMINE SYNTHETASE INHIBITORS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2014-09-18 | — | — | US | claimed |
| EP-4541812-A2 | GENERATION OF A HIGH PRODUCING RECOMBINANT CHINESE HAMSTER OVARY CELL LINE FOR THERAPEUTIC PROTEIN PRODUCTION | Sanofi (FR) | 2025-04-23 | — | — | EP | disclosed |
| EP-4214308-B1 | GENERATION OF A HIGH PRODUCING RECOMBINANT CHINESE HAMSTER OVARY CELL LINE FOR THERAPEUTIC PROTEIN PRODUCTION | SANOFI SA (FR) | 2024-11-20 | — | — | EP | disclosed |
| EP-4419094-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPROLIFERATIVE, INFLAMMATORY, AND IMMUNOLOGICAL DISEASES, AND INFECTIONS | Edison Oncology (US) | 2024-08-28 | — | — | EP | disclosed |
| US-20240043878-A1 | GENERATION OF A HIGH PRODUCING RECOMBINANT CHINESE HAMSTER OVARY CELL LINE FOR THERAPEUTIC PROTEIN PRODUCTION | SANOFI (FR) | 2024-02-08 | — | — | US | disclosed |
| EP-4214308-A1 | GENERATION OF A HIGH PRODUCING RECOMBINANT CHINESE HAMSTER OVARY CELL LINE FOR THERAPEUTIC PROTEIN PRODUCTION | Sanofi (FR) | 2023-07-26 | — | — | EP | disclosed |
| WO-2023069727-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPROLIFERATIVE, INFLAMMATORY, AND IMMUNOLOGICAL DISEASES, AND INFECTIONS | EDISON ONCOLOGY (US) | 2023-04-27 | — | — | WO | disclosed |
| WO-2022058603-A1 | GENERATION OF A HIGH PRODUCING RECOMBINANT CHINESE HAMSTER OVARY CELL LINE FOR THERAPEUTIC PROTEIN PRODUCTION | SANOFI (FR) | 2022-03-24 | — | — | WO | disclosed |
| US-10947598-B2 | Methods for determining the metabolic status of lymphomas | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2021-03-16 | — | — | US | disclosed |
| EP-3356551-B1 | METHODS FOR DETERMINING THE METABOLIC STATUS OF B-LYMPHOMAS | INST NAT SANTE RECH MED (FR) | 2020-09-02 | — | — | EP | disclosed |
| US-20180282816-A1 | METHODS FOR DETERMINING THE METABOLIC STATUS OF LYMPHOMAS | Université Côte d'Azur (FR) | 2018-10-04 | — | — | US | disclosed |
| EP-3356551-A1 | METHODS FOR DETERMINING THE METABOLIC STATUS OF LYMPHOMAS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2018-08-08 | — | — | EP | disclosed |
| US-20140271926-A1 | METHODS OF USE OF GLUTAMINE SYNTHETASE INHIBITORS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2014-09-18 | — | — | US | disclosed |
| WO-2012095514-A1 | RECOMBINANT PROTEIN PRODUCTION SYSTEM | VIVALIS (FR) | 2012-07-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947598-B2 | Methods for determining the metabolic status of lymphomas | GAPDH, GCDH, IDH2 | ALDH1A1 571/4885MEN1 4447/4885CYP1A2 998/4885 |
| US-20240043878-A1 | GENERATION OF A HIGH PRODUCING RECOMBINANT CHINESE HAMSTER OVARY CELL LINE FOR THERAPEUTIC PROTEIN PRODUCTION | DHODH, GLUL, GLS2 | ALDH1A1 1617/4885MEN1 2961/4885CYP1A2 2401/4885 |
| US-20180282816-A1 | METHODS FOR DETERMINING THE METABOLIC STATUS OF LYMPHOMAS | GAPDH, IDH2, GCDH | ALDH1A1 416/4885MEN1 4454/4885CYP1A2 832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.